Jiali Dai

机构：Jiangsu Province Hospital, Nanjing Medical University · ORCID：0000-0003-4509-1391

发表论文 23 篇 · 总被引 430 次 · h-index 10

代表论文

• LncRNA LINC00969 promotes acquired gefitinib resistance by epigenetically suppressing of NLRP3 at transcriptional and posttranscriptional levels to inhibit pyroptosis in lung cancer (2023 · Cell Death and Disease · 被引 104)
• B4GALT1 promotes immune escape by regulating the expression of PD-L1 at multiple levels in lung adenocarcinoma (2023 · Journal of Experimental & Clinical Cancer Research · 被引 78)
• NNMT promotes acquired EGFR-TKI resistance by forming EGR1 and lactate-mediated double positive feedback loops in non-small cell lung cancer (2025 · Molecular Cancer · 被引 52)
• Cancer-associated fibroblasts promote EGFR-TKI resistance via the CTHRC1/glycolysis/H3K18la positive feedback loop (2025 · Oncogene · 被引 49)
• Habitat radiomics analysis for progression free survival and immune-related adverse reaction prediction in non-small cell lung cancer treated by immunotherapy (2025 · Journal of Translational Medicine · 被引 27)
• PBRM1 mutation as a predictive biomarker for immunotherapy in multiple cancers (2023 · Frontiers in Genetics · 被引 24)